Drugs / MDX2004
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07110584 | Oct 2025 → Jun 2031 expected | metastatic neoplasm | ModeX Therapeutics, An OPKO Health Company | Recruiting | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2025-10-28 | OPKO Health, Inc. | OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers opko.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MDX2004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07110584 ↗ |
| Route | Intravenous | “intravenous (IV) infusion” NCT07110584 ↗ |